Merck Lowers 2013 Guidance

Pharmaceutical giant Merck  (NYSE: MRK  )  doesn't have the goods for what ails you this quarter. First-quarter earnings came up short of top-line consensus estimates by Capital IQ analysts, even as it beat on the bottom line. Even so, it had to lower guidance for the full year as competition from generic drugs continue to sap its strength.

Merck reported revenues for the three months ending on March 31 of $10.67 billion, down 9% from the same period last year, when it recorded revenues of $11.73 billion, and falling short of analysts' expectations of $11.10 billion. The pharma recorded GAAP profits $0.52 per share, 7% below the $0.56 it posted in the year-ago quarter but well ahead of the $0.46 in GAAP earnings Wall Street expected.

Merck now expects full-year 2013 non-GAAP earnings per share to be in a range of $3.45 and $3.55, or $0.15 per share lower than what it guided toward at the end of 2012. Generic competition for its asthma and allergy drug Singulair caused sales of the drug to plunge 75% in the quarter.

While saying he still remains confident of the pharma's future opportunities, Merck Chairman and CEO Kenneth C. Frazier said: "Our first quarter performance reflects the challenges of major patent expiries coupled with the impact of currency and other headwinds. During the quarter, we took focused actions to reach our EPS target while at the same time advancing Merck's pipeline in our laboratories and through strategic deals and partnerships."

Merck operates and has customers in more than 140 countries around the globe. It had revenues of $47.3 billion in 2012.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2402214, ~/Articles/ArticleHandler.aspx, 8/29/2014 2:04:22 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement